# FDA Inspection 1098391 - Novartis Gene Therapies, Inc. - August 02, 2019

Source: https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/b248dcf9-f018-40c9-81cf-1316bcb9a3bf
Source feed: FDA_Inspections

> FDA Inspection 1098391 for Novartis Gene Therapies, Inc. on August 02, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1098391
- Company Name: Novartis Gene Therapies, Inc.
- Inspection Date: 2019-08-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1155029 - 2021-08-27](https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/5fc85103-2cc5-4449-a02e-e29d0a3c1dd0)

Company: https://www.keypedia.com/companies/novartis-gene-therapies-inc/04406f28-2c1b-4c68-ab75-a9862bfc9169

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d